Disruption of nucleocytoplasmic trafficking of cylin DI and topoisomerase II by sanguinarine

BMC Cell Biology

Volumn 7, Issue , 2006, Pages

  Holy, Jon ^a   Lamont, Genelle ^a   Perkins, Edward ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); SANGUINARINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL STRUCTURE; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DNA SYNTHESIS INHIBITION; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INHIBITION KINETICS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN LOCALIZATION; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZOPHENANTHRIDINES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN D1; CYTOPLASM; DNA TOPOISOMERASES, TYPE II; DNA, NEOPLASM; FEMALE; HUMANS; ISOQUINOLINES;

MINK CELL FOCUS-FORMING VIRUS;

EID: 33645840140     PISSN: 14712121     EISSN: 14712121     Source Type: Journal    
DOI: 10.1186/1471-2121-7-13     Document Type: Article

References (58)

1. Vogel VJ: American Indian Medicine. Norman, OK, University of Oklahoma Press; 1990.
2. Pommier Y: Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I wieht camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints. Curr Med Chem Anti-Cancer Agents 2004, 4:429-434.
3. Adhami VM, Aziz MH, Mukhtar H, Ahmad N: Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratocytes. Clin Cancer Res 2003, 9:3176-3182.
4. Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H, Ahmad N: Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 2004, 3(8):933-940.
5. Ding Z, Tang SC, Weerasinghe P, Yang X, Pater A, Liepins A: The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. Biochem Pharmacol 2002, 63:1415-1421.
6. Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H: Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 2000, 6:1524-1528.
7. Wolff J, Knipling L: Antimicrotubule properties of benzophen-anthridine alkaloids. Biochemistry 1993, 32:13334-13339.
8. Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, Lazo JS: The Benzo[c]phenanthridine Alkaloid, Sanguinarine, Is a Selective, Cell-active Inhibitor of Mitogen-activated Protein Kinase Phosphatase-1. J Biol Chem 2005, 280(19):19078-19086.
9. Wang BH, Lu ZX, Polya GM: Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids. Planta Med 1997, 63:494-498.
10. Chaturvedi MM, Kumar A, Darnay BG, Chainy GBN, Agarwal S, Aggarwal BB: Sanguinarine (Pseudochelerythrine) is a potent inhibitor of NF-kB activation, IkBa phosphorylation, and degradation. J Biol Chem 1997, 272:30129-30134.
11. Barreto MC, Pinto RE, Arrabaca JD, Pavao ML: Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. Toxicol Lett 2003, 146:37-47.
12. Straub KD, Carver P: Sanguinarine, inhibitor of Na-K dependent ATPase. Biochem Biophys Res Comm 1975, 62:913-922.
13. Vallejos RH: Uncoupling photosynthetic phosphorylation by benzophenanthridine alkaloids. Biophys Biochem Acta 1973, 292:193-196.
14. Ulrichova J, Dvorak Z, Vicar J, Lata J, Smrzova J, Sedo A, Somanek V: Cytotoxicity of natural compounds in hepatocyte cell culture models. The case of quaterinary benzo[c]phenanthridine alkaloids. Toxicol Lett 2001, 125:125-132.
15. Nandi R, Maiti M: Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol 1985, 34(321):.
16. Saran A, Srivastava S, Coutinho E, Maiti M: 1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J Biochem Biophys 1995, 32:74-77.
17. Schmeller T, Latz-Bruning B, Wink M: Biochemical activities of berberine, palmatine, and sanguinarine mediating chemical defence aginst microorganisms and herbivores. Phytochemistry 1997, 44:257-266.
18. Tanabe H, Suzuki H, Mizukami H, Inoue M: Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells. Biochem Pharmacol 2005, 70:1176-1184.
19. Lapillonne H, Konopleva M, Tsao T, Gold D, McQueen T, Sutherland RL, Madden T, Andreeff M: Activation of peroxisome proliferator-activated receptor g by a novel synthetic triterpenoid 2-cyano-3, 12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. Cancer Res 2003, 63:5926-5939.
20. Dragnev KH, Pitha-Rowe I, Ma Y, Petty WJ, Sekula D, Murphy B, Rendi M, Suh N, Freemantle SJ, Dmitrovsky E: Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications or combination therapy. Clin Cancer Res 2004, 10:2570-2577.
21. Erba E, Bergamaschi D, Bassano L, Damia G, Ronzoni S, Faircloth GT, D'Incalci M: Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action. Europ J Cancer 2001, 37:97-105.
22. Facompre M, Tardy C, Bal-Mahieu C, Colson P, Perez C, Manzanares I, Cuevas C, Bailly C: Lamellarin D: a novel potent inhibitor of topoisomerase I. Cancer Res 2003, 63:7392-7399.
23. Kuo PL, Lin CC: Tetrandrine-induced cell cycle arrest and apoptosis in HepG2 cells. Life Sciences 2003, 73:243-252.
24. Martinez EJ, Owa T, Schreiber SL, Corey EJ: Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743. Proc Natl Acad Sci U S A 1999, 96:3496-3501.
25. Meng L, Zhang H, Hayward L, Takemura H, Shao RG, Pommier Y: Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res 2004, 64:9086-9092.
26. Chowdhury AR, Mandal S, Mittra B, Sharma S, Mukhopadhyay S, Majumder HK: Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives. Med Sci Monit 2002, 8:BR254-260.
27. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K: Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J 2000, 350:757-763.
28. Nagase M, Oto J, Sugiyama S, Yube K, Takaishi Y, Sakato N: Apoptosis induction in HL-60 cells and inhibition of topoisomerase II by triterpene celastrol. Biosci Biotechnol Biochem 2003, 67:1883-1887.
29. Syrovets T, Buchele B, Gedig E, Slupsky JR, Simmet T: Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha. Mol Pharmacol 2000, 58(1):71-81.
30. Wada S, Iida A, Tanaka R: Screening of triterpenoids isolated from Phyllanthus flexuosus for DNA topoisomerase inhibitory activity. J Nat Prod 2001, 64(12):1545-1547.
31. Schmidt ML, Kuzmanoff KL, Indeck LL, Pezzuto JM: Betulinic acid induces apoptosis in human neuroblastoma cell lines. Eur J Cancer 1997, 33:2007-2010.
32. Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM: Betulinic acid: a new cytotoxic agent against malignant brain tumor cells. Int J Cancer 1999, 82:435-441.
33. Tokuda H, Ohigashi H, Koshimuzu K, Yohei I: Inhibitory effects of ursolic acid and oleanolic acid on skin tumor promotion by 12-o-tetradecanoyl-phorbol-13-acetate. Cancer Lett 1986, 33:279-285.
34. Pisha E, Chai H, Lee IS, Chagwedera TE, Farnsworth NR, Cordell GA, Beecher CWW, Fong HHS, Kinghorn AD, Brown DM, Wani MC, Wall ME, Hieken TJ, DasGupta TK, Pezzuto JM: Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1995, 1:1046-1051.
35. Engel R, Valkov NI, Gump JL, Hazlehurst L, Dalton WS, Sullivan DM: The cytoplasmic trafficking of DNA topoisomerase IIalpha correlates with etoposide resistance in human myeloma cells. Exp Cell Res 2004, 295(2):421-431.
36. Oloumi A, MacPhail SH, Johnston PJ, Banath JP, Olive PL: Changes in subcellular distribution of topoisomerase II alpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res 2000, 60(20):5747-5753.
37. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998, 273:9357-9360.
38. Kurokawa H, Nishio K, Fukumoto H, Tomonari A, Suzuki T, Saijo N: Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol Rep 1999, 6:33-37.
39. Devarajan E, Sahin AA, Chen JS, Krishnamurthy RR, Aggarwal N, Brun AM, Sapino A, Zhang F, Sharma D, Yang XH, Tora AD, Mehta K: Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002, 21:8843-8851.
40. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD: Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res 2001, 61:348-354.
41. Hagting A, Jackman M, Simpson K, Pines J: Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal. Curr Biol 1999, 9(13):680-689.
42. Hagting A, Karlsson C, Clute P, Jackman M, Pines J: MPF localization is controlled by nuclear export. Embo J 1998, 17(14):4127-4138.
43. Porter LA, Donoghue DJ: Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog Cell Cycle Res 2003, 5:335-347.
44. Yang J, Song H, Walsh S, Bardes ES, Kornbluth S: Combinatorial control of cyclin B1 nuclear trafficking through phosphorylation at multiple sites. J Biol Chem 2001, 276(5):3604-3609.
45. Alt JR, Cleveland JL, Hanink M, Diehl JA: Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Devel 2000, 14:3102-3114.
46. Yang J, Bardes ES, Moore JD, Brennan J, Powers MA, Kornbluth S: Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1. Genes Dev 1998, 12(14):2131-2143.
47. Gallant P, Nigg EA: Identification of a novel vertebrate cyclin: cyclin B3 shares properties with both A- and B-type cyclins. EMBO J 1994, 13:595-605.
48. Jackman M, Kubota Y, Elzen ND, Hagting A, Pines J: Cyclin A- and cyclin E-Cdk complexes shuttle between the nucleus and cytoplasm. Mol Biol Cell 2002, 13:1030-1045.
49. Moore JD, Yang J, Truant R, Kornbluth S: Nuclear import of Cdk/cyclin complexes: identification of distinct mechanisms for import of Cdk2/ cyclin E and Cdc2/cyclin B1. J Cell Biol 1999, 144:213-224.
50. Gallant P, Fry AM, Nigg EA: Protein kinases in the control of mitosis: focus in nucleocytoplasmic trafficking. J Cell Sci 1995, 19:21-28.
51. Lu F, Gladden AB, Diehl JA: An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 2003, 63(21):7056-7061.
52. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, Hara M, Saito I: Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 1998, 16(13):1701-1712.
53. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, Senderowicz AM, Conti CJ, Knudsen ES: Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 2003, 278(32):30339-30347.
54. Diehl JA, Zindy F, Sherr CJ: Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997, 11:957-972.
55. Kim DK, Baek JH, Kang CM, Yoo MA, Sung JW, Chung HY, Kim ND, Choi YH, Lee SH, Kim KW: Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int J Cancer 2000, 87(5):629-636.
56. Stiborova M, Simanek V, Frei E, Hobza P, Ulrichova J: DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem-Biol Inter 2002, 140:231-242.
57. Kao GD, McKenna WG, Yen TJ: Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells. Oncogene 2001, 20:3486-3496.
58. Slaninova I, Taborska E, Bochorakova H, Slanina J: Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells. Cell Biol Toxicol 2001, 17(1):51-63.